Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
03/30/2011 | CN101253262B New esterases and their use for processes for kinetic resolution of butinolesters |
03/30/2011 | CN101186933B Culture of bacillus alcaligenes and method for preparing glycolic acid by using the same to hydrolyzing nitrile |
03/30/2011 | CN101070530B Low-temperature alkaline phosphatidase A1 and coding gene thereof |
03/29/2011 | US7915487 Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same |
03/29/2011 | US7915486 Plastidic phosphoglucomutase genes |
03/29/2011 | US7915485 Nodulation factor binding element for use in developing nitrogen-fixing root nodules in plants |
03/29/2011 | US7915484 Transgenic freeze and drought resistant plants; crops with enhanced resistance to enviromental stresses; plant transformed by a Protein Kinase Stress-Related Protein (PKSRP) coding nucleic acid |
03/29/2011 | US7915384 Chimeric peptides for the regulation of GTPases |
03/29/2011 | US7915381 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer |
03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
03/29/2011 | US7915039 Using collagenase to digest decidual membrane tissue and isolate progenitor cells for use in tissue engineering; regenerative medicine; wound healing agents |
03/29/2011 | US7915026 Host cells for production of isoprenoid compounds |
03/29/2011 | US7915025 In vivo incorporation of unnatural amino acids |
03/29/2011 | US7915024 Feed containing bacillus keratinase; efficient utilization |
03/29/2011 | US7915022 Carbonyl reductase, gene thereof and method of using the same |
03/29/2011 | US7915021 Mutant firefly luciferase |
03/29/2011 | US7915016 Recovering and replicating RNA sequences from preferential tissues; organ specific RNA libraries |
03/29/2011 | US7914985 Alanine transaminase enzymes and methods of use |
03/29/2011 | CA2515686C Deglycosylated enzymes for conjugates |
03/29/2011 | CA2447040C Assays, methods and means |
03/29/2011 | CA2392653C Production of vaccines |
03/29/2011 | CA2379571C Process for the production of a heterologous peptide by autoproteolytic cleavage in vitro |
03/29/2011 | CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
03/29/2011 | CA2227342C Screening methods for enzymes and enzyme kits |
03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
03/29/2011 | CA2198828C Method for increasing thermostability in cellulase emzymes by removal of the cellulose binding domains |
03/24/2011 | WO2011035134A1 Microdevices for implantation comprising thermogenic cells for treating a metabolic disease |
03/24/2011 | WO2011035029A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
03/24/2011 | WO2011035027A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
03/24/2011 | WO2011034907A2 Protein kinase conjugates and inhibitors |
03/24/2011 | WO2011034449A1 Fusion polypeptides and uses thereof |
03/24/2011 | WO2011034406A2 Rhodanobacter ginsenosidimutans kctc22231t-derived ginsenoside glycosidase, and use thereof |
03/24/2011 | WO2011034348A2 Enantioselective amidase specific to l-amino acid amide, and dna encoding same |
03/24/2011 | WO2011034199A1 Glycerol-3-phosphate acyl transferase |
03/24/2011 | WO2011034131A1 Agent for the prevention or treatment of inflammatory bowel disease |
03/24/2011 | WO2011034108A1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
03/24/2011 | WO2011033961A1 Phospholipase a1, gene encoding phospholipase a1, expression vector, transformant, process for production of phospholipase a1 |
03/24/2011 | WO2011033633A1 Lactase preparation |
03/24/2011 | WO2011033506A2 Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage |
03/24/2011 | WO2011033129A1 Modified gram-negative bacteria for use as vaccines |
03/24/2011 | WO2011033039A1 An enzymatically catalyzed method of preparing mono-acylated polyols |
03/24/2011 | WO2011032990A1 Preparation of beta-amino acids |
03/24/2011 | WO2011032988A1 Storage-stable liquid detergent or cleaning agent containing proteases |
03/24/2011 | WO2011032934A1 Method for the enzymatic production of 3-hydroxy-s-methylbutyric acid from acetone and acetyl-coa |
03/24/2011 | WO2011032213A1 Nucleic acid molecule encoding triterpenoid synthase |
03/24/2011 | WO2010151656A3 Compositions and methods for identification of parp function, inhibitors, and activators |
03/24/2011 | US20110072541 Marker free transgenic plants engineering the chloroplast genome without the use of antibiotic selection |
03/24/2011 | US20110072540 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
03/24/2011 | US20110072527 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
03/24/2011 | US20110071285 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
03/24/2011 | US20110071165 Aza- and polyazanthranyl amides and their use as medicaments |
03/24/2011 | US20110071149 Selective kinase inhibitors |
03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
03/24/2011 | US20110071125 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
03/24/2011 | US20110071124 Compounds that Inhibit Production of sAPPB and AB and Uses Thereof |
03/24/2011 | US20110071092 Anti-inflammatory compounds and uses thereof |
03/24/2011 | US20110071073 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
03/24/2011 | US20110071068 Subtilases |
03/24/2011 | US20110071031 Compositions, methods, and kits for isolating and analyzing nucleic acids using an anion exchange material |
03/24/2011 | US20110071029 Wheat plants having increased resistance to imidazolinone herbicides |
03/24/2011 | US20110070649 Method for manufacturing glycoproteins having human-type glycosylation |
03/24/2011 | US20110070622 Purification of collagenases from clostridium histolyticum liquid culture |
03/24/2011 | US20110070621 Multivalent Clostridial Toxins |
03/24/2011 | US20110070612 Gene inactivated mutants with altered protein production |
03/24/2011 | US20110070610 Processing Enzymes Fused to Basic Protein Tags |
03/24/2011 | US20110070607 Glycoprotein synthesis and remodeling by enzymatic transglycosylation |
03/24/2011 | US20110070595 Methods for the identification of parp interacting molecules and for purification of parp proteins |
03/24/2011 | US20110070579 Polyketide synthase-nonribosomal peptide synthetase gene |
03/24/2011 | US20110070333 Novel process for enzymatic acrylamide reduction in food products |
03/24/2011 | US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN |
03/24/2011 | US20110070219 High pressure protein crystallization |
03/24/2011 | US20110070214 Bacitracin metal complexes used as bleach catalysts |
03/24/2011 | CA2774529A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
03/24/2011 | CA2774408A1 Glycerol-3-phosphate acyltransferase |
03/24/2011 | CA2774333A1 Fusion polypeptides and uses thereof |
03/24/2011 | CA2774166A1 Nucleic acid molecule encoding triterpenoid synthase |
03/24/2011 | CA2774053A1 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
03/24/2011 | CA2773985A1 Protein kinase conjugates and inhibitors |
03/24/2011 | CA2773592A1 Method and composition for treating alzheimer-type dementia |
03/24/2011 | CA2772279A1 Method for the enzymatic production of 3-hydroxy-s-methylbutyric acid from acetone and acetyl-coa |
03/23/2011 | EP2299530A1 Novel enzyme electrode, and fuel cell comprising the enzyme electrode |
03/23/2011 | EP2299269A1 Protein fragment complementation assay based on beta-lactamase |
03/23/2011 | EP2298935A1 Methods for detection of a target nucleic acid sequence |
03/23/2011 | EP2298913A1 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi |
03/23/2011 | EP2298911A2 Methods for producing polypeptides in respiratory-deficient cells |
03/23/2011 | EP2298909A2 Novel peptide-forming enzyme gene |
03/23/2011 | EP2298908A2 Novel peptide-forming enzyme gene |
03/23/2011 | EP2298907A2 Novel peptide-forming enzyme gene |
03/23/2011 | EP2298906A2 Novel peptide-forming enzyme gene |
03/23/2011 | EP2298905A2 Novel peptide-forming enzyme gene |
03/23/2011 | EP2298904A1 Xylanases, nucleic acids encoding them and methods for making and using them |
03/23/2011 | EP2298903A2 Alpha-amylase mutants with altered properties |
03/23/2011 | EP2298902A1 Luciferase biosensor |
03/23/2011 | EP2298901A2 Novel herbicide resistance genes |
03/23/2011 | EP2298876A1 Novel cbh1 homologs and variant cbh1 cellulases |
03/23/2011 | EP2298875A2 Variants with altered properties |
03/23/2011 | EP2298874A1 Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof |
03/23/2011 | EP2298873A1 Lipolytic enzyme variants |
03/23/2011 | EP2298872A2 Polypeptides having lipase activity and polynucleotides encoding same |
03/23/2011 | EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them |